Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    AURYXIA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 90Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akebia Announces Positive Opinion of EMA Agency for Xoanacyl
    Akebia Announces Positive Opinion of EMA Agency for Xoanacyl

    03 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/03/3055119/37519/en/Akebia-Therapeutics-Announces-Positive-Opinion-of-European-Medicines-Agency-for-XOANACYL-an-Oral-Therapy-for-Chronic-Kidney-Disease-Licensed-to-Averoa.html

    GLOBENEWSWIRE
    03 Apr 2025
    Share Share
    Averoa Gets Positive Opinion from EMA for Xoanacyl® for CKD
    Averoa Gets Positive Opinion from EMA for Xoanacyl® for CKD

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3054026/0/en/AVEROA-Receives-Positive-Opinion-from-the-European-Medicines-Agency-for-XOANACYL-an-Oral-Therapy-for-Chronic-Kidney-Disease-CKD.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share
    Akebia Therapeutics Reports Q2 2024 Results And Business Highlights
    Akebia Therapeutics Reports Q2 2024 Results And Business Highlights

    08 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akebia-therapeutics-reports-second-quarter-2024-financial-results-and-recent-business-highlights-302217366.html

    PR NEWSWIRE
    08 Aug 2024
    Share Share
    Akebia Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia
    Akebia Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia

    29 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-positive-top-line-results-of-phase-4-impact-study-of-auryxia-ferric-citrate-for-in-center-and-home-dialysis-patients-301866373.html

    PR NEWSWIRE
    29 Jun 2023
    Share Share
    Enforcement Report - Week of February 24, 2021
    Enforcement Report - Week of February 24, 2021

    24 Feb 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-24-2021-1614247020.pdf

    FDA
    24 Feb 2021
    Share Share
    Enforcement Report - Week of December 30, 2020
    Enforcement Report - Week of December 30, 2020

    30 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-30-2020-1609403374.pdf

    FDA
    30 Dec 2020
    Share Share